232 related articles for article (PubMed ID: 27259214)
1. [Multifunctional ligands--a new approach in the search for drugs against multi-factorial diseases].
Wichur T; Malawska B
Postepy Hig Med Dosw (Online); 2015 Jan; 69():1423-34. PubMed ID: 27259214
[TBL] [Abstract][Full Text] [Related]
2. Multi-targeting Strategies for Alzheimer's Disease Therapeutics: Pros and Cons.
Das S; Basu S
Curr Top Med Chem; 2017; 17(27):3017-3061. PubMed ID: 28685694
[TBL] [Abstract][Full Text] [Related]
3. Multi-target-directed ligands in Alzheimer's disease treatment.
Bajda M; Guzior N; Ignasik M; Malawska B
Curr Med Chem; 2011; 18(32):4949-75. PubMed ID: 22050745
[TBL] [Abstract][Full Text] [Related]
4. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
5. Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update.
de Freitas Silva M; Dias KST; Gontijo VS; Ortiz CJC; Viegas C
Curr Med Chem; 2018; 25(29):3491-3525. PubMed ID: 29332563
[TBL] [Abstract][Full Text] [Related]
6. Novel multi-target directed ligand-based strategies for reducing neuroinflammation in Alzheimer's disease.
Wenzel TJ; Klegeris A
Life Sci; 2018 Aug; 207():314-322. PubMed ID: 29940242
[TBL] [Abstract][Full Text] [Related]
7. Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease.
Spilovska K; Korabecny J; Nepovimova E; Dolezal R; Mezeiova E; Soukup O; Kuca K
Curr Top Med Chem; 2017; 17(9):1006-1026. PubMed ID: 27697055
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
9. Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design.
Kumar A; Tiwari A; Sharma A
Curr Neuropharmacol; 2018; 16(6):726-739. PubMed ID: 29542413
[TBL] [Abstract][Full Text] [Related]
10. Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.
Wang L; Bharti ; Kumar R; Pavlov PF; Winblad B
Eur J Med Chem; 2021 Jan; 209():112915. PubMed ID: 33139110
[TBL] [Abstract][Full Text] [Related]
11. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease.
Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML
Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079
[TBL] [Abstract][Full Text] [Related]
12. Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease.
Kumar N; Kumar V; Anand P; Kumar V; Ranjan Dwivedi A; Kumar V
Bioorg Med Chem; 2022 May; 61():116742. PubMed ID: 35398739
[TBL] [Abstract][Full Text] [Related]
13. A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer's disease.
Zhang X; He X; Chen Q; Lu J; Rapposelli S; Pi R
Bioorg Med Chem; 2018 Feb; 26(3):543-550. PubMed ID: 29310862
[TBL] [Abstract][Full Text] [Related]
14. A step further towards multitarget drugs for Alzheimer and neuronal vascular diseases: targeting the cholinergic system, amyloid-β aggregation and Ca(2+) dyshomeostasis.
León R; Marco-Contelles J
Curr Med Chem; 2011; 18(4):552-76. PubMed ID: 21143111
[TBL] [Abstract][Full Text] [Related]
15. The multifactorial nature of Alzheimer's disease for developing potential therapeutics.
Carreiras MC; Mendes E; Perry MJ; Francisco AP; Marco-Contelles J
Curr Top Med Chem; 2013; 13(15):1745-70. PubMed ID: 23931435
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core.
Lin H; Li Q; Gu K; Zhu J; Jiang X; Chen Y; Sun H
Curr Top Med Chem; 2017; 17(27):3000-3016. PubMed ID: 28714419
[TBL] [Abstract][Full Text] [Related]
17. Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents.
George N; Jawaid Akhtar M; Al Balushi KA; Alam Khan S
Bioorg Chem; 2022 Oct; 127():105941. PubMed ID: 35714473
[TBL] [Abstract][Full Text] [Related]
18. Multicomponent Reactions for Multitargeted Compounds for Alzheimer`s Disease.
Ismaili L; do Carmo Carreiras M
Curr Top Med Chem; 2017; 17(31):3319-3327. PubMed ID: 29332584
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease.
León R; Garcia AG; Marco-Contelles J
Med Res Rev; 2013 Jan; 33(1):139-89. PubMed ID: 21793014
[TBL] [Abstract][Full Text] [Related]
20. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease.
Li Q; He S; Chen Y; Feng F; Qu W; Sun H
Eur J Med Chem; 2018 Oct; 158():463-477. PubMed ID: 30243151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
